Company Overview
- Headquarters
- US
- Website
- vaccinogentx.com
- Employees
- 8
- Founded in
- 2007
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is Vaccinogen
Vaccinogen is a small US biotechnology company established in 2007. With only three employees, the company focuses its efforts on the development and commercialization of a groundbreaking cancer vaccine. Vaccinogen's core product, OncoVAX, is a novel vaccine designed to treat Stage II Colon Cancer. The vaccine has demonstrated significant efficacy in clinical trials, reducing the recurrence rate of the disease from one in three in untreated patients to one in nine for those treated with OncoVAX. OncoVAX has received Fast-Track designation and Special Protocol Assessment from the FDA, recognizing its potential to address a significant unmet medical need. Vaccinogen is currently conducting a Pivotal Phase IIIb Trial with the goal of securing FDA approval for OncoVAX by 2027. For more information about Vaccinogen and OncoVAX, visit their website at vaccinogen-oncovax.com.
Vaccinogen Industry Tags
Companies Similar to Vaccinogen
Analyze industry trends and opportunities by examining competitors and companies comparable to Vaccinogen, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |